(Q39738823)

14 September 2017

1 reference

title

Drug disposition in obese humans. An update (English)

1 reference

14 September 2017

0 references

2

D J Greenblatt

1 reference

14 September 2017

1

D R Abernethy

1 reference

14 September 2017

1 May 1986

1 reference

Clinical Pharmacokinetics

14 September 2017

1 reference

14 September 2017

11

1 reference

14 September 2017

199-213

1 reference

14 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198611030-00002

14 September 2017

0 references

cites work

Body fatness, relative weight and frame size in young adults.

1 reference

12 December 2020

Lidocaine disposition in obesity.

1 reference

12 December 2020

Assessment of Methods to Identify Sources of Interindividual Pharmacokinetic Variations

1 reference

12 December 2020

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

1 reference

12 December 2020

Dimorphic cardiac adaptation to obesity and arterial hypertension

1 reference

12 December 2020

Prednisolone disposition in obese men

1 reference

12 December 2020

Prolongation of drug half-life due to obesity: studies of desmethyldiazepam (clorazepate).

1 reference

12 December 2020

Digoxin metabolism in obesity

1 reference

12 December 2020

IN VITRO QUANTITATION OF BENZODIAZEPINE LIPOPHILICITY: RELATION TO IN VIVO DISTRIBUTION

1 reference

12 December 2020

Rats as models for the study of obesity

1 reference

12 December 2020

Serum alpha 1-acid glycoprotein and the binding of drugs in obesity

1 reference

12 December 2020

Theophylline disposition in obese rats

1 reference

12 December 2020

Fatty liver hepatitis and cirrhosis in obese patients

1 reference

12 December 2020

Amikacin pharmacokinetics in morbidly obese patients undergoing gastric-bypass surgery

1 reference

12 December 2020

Pharmacokinetics of drugs in obesity

1 reference

12 December 2020

Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age.

1 reference

12 December 2020

Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen

1 reference

12 December 2020

The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and Triazolam

1 reference

12 December 2020

Estimating creatinine clearance in morbidity obese patients

1 reference

12 December 2020

Extrahepatic sulfation and glucuronidation in the rat in vivo. Determination of the hepatic extraction ratio of harmol and the extrahepatic contribution to harmol conjugation

1 reference

12 December 2020

Total body water volumes for adult males and females estimated from simple anthropometric measurements

1 reference

12 December 2020

Dietary obesity: permanent changes in body weight [proceedings]

1 reference

12 December 2020

Obesity, sex, and acetaminophen disposition

1 reference

12 December 2020

Effect of Obesity on Gentamicin Pharmacokinetics

1 reference

12 December 2020

Lean body mass in obesity

1 reference

12 December 2020

Genetically transmitted obesity in rodents

1 reference

12 December 2020

Effect of age, gender, and obesity on midazolam kinetics.

1 reference

12 December 2020

Tobramycin pharmacokinetics in morbidly obese patients

1 reference

12 December 2020

Theophylline disposition in obesity

1 reference

12 December 2020

Alterations in drug distribution and clearance due to obesity

1 reference

12 December 2020

Obesity and cardiac function

1 reference

12 December 2020

The effect of obesity on apparent volume of distribution of theophylline

1 reference

12 December 2020

Indices of relative weight and obesity

1 reference

12 December 2020

The clinical pharmacokinetics of phenytoin

1 reference

12 December 2020

Cimetidine disposition in obesity

1 reference

12 December 2020

Intravenous diphenylhydantoin in treatment of acute repetitive seizures

1 reference

12 December 2020

Mechanisms of hypertension in the overweight

1 reference

12 December 2020

Vancomycin pharmacokinetics in normal and morbidly obese subjects

1 reference

12 December 2020

Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs

1 reference

12 December 2020

Amikacin pharmacokinetics in morbidly obese patients

1 reference

12 December 2020

Commentary: a physiological approach to hepatic drug clearance

1 reference

12 December 2020

Digoxin disposition in obesity: Clinical pharmacokinetic investigation

1 reference

12 December 2020

Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients

1 reference

12 December 2020

Administration o gentamicin to obese patients

1 reference

12 December 2020

Obesity in hypertension: How innocent a bystander?

1 reference

12 December 2020

1 reference

12 December 2020

The distribution and concentration of tritiated digoxin in human tissues

1 reference

12 December 2020

Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects

1 reference

12 December 2020

Diazepam disposition determinants.

1 reference

12 December 2020

Health implications of obesity. National Institutes of Health Consensus Development Conference Statement

1 reference

12 December 2020

Obese, a new mutation in the house mouse

1 reference

12 December 2020

Tissue distribution of diazepam and its metabolite desmethyldiazepam: a human autopsy study.

1 reference

12 December 2020

Ibuprofen disposition in obese individuals

1 reference

12 December 2020

Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction

1 reference

12 December 2020

Thiopental disposition in lean and obese patients undergoing surgery.

1 reference

12 December 2020

A methodological critique of the 'ideal weight' concept

1 reference

12 December 2020

Hypertension in obese patients: hemodynamic and volume studies

1 reference

12 December 2020

Age, disease, and cimetidine disposition in healthy subjects and chronically ill patients

1 reference

12 December 2020

Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration

1 reference

12 December 2020

Body Weight, Health, and Longevity

1 reference

12 December 2020

Caffeine disposition in obesity

1 reference

12 December 2020

Cimetidine clearance in the obese

1 reference

12 December 2020

Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man

1 reference

12 December 2020

The influence of body weight, sex and age on the dosage of thiopentone.

1 reference

12 December 2020

A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects

1 reference

12 December 2020

Procainamide Disposition in Obesity

1 reference

12 December 2020

Increased glomerular filtration rate and adrenocortical function in obese women

1 reference

12 December 2020

In vitro hepatic drug metabolism and microsomal enzyme induction in genetically obese rats

1 reference

12 December 2020

10.2165/00003088-198611030-00002

Identifiers

DOI

1 reference

PubMed ID

3524955

Dimensions Publication ID

14 September 2017

0 references

1 reference

PubMed ID

3524955